Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
927.15
3.50 (0.38%)
< Home < Back

Natco Pharma informs about disclosure

Date: 05-12-2022
Natco Pharma has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for V C Nannapaneni.

The above information is a part of company’s filings submitted to BSE.